Back

Developmental Dysplasia of the Hip

Also known as: DDH

Developmental dysplasia of the hip is a spectrum of abnormal hip joint development, from mild acetabular dysplasia to frank hip dislocation. It results from abnormal development of the acetabulum, femoral head, or both, with associated capsular and ligamentous laxity.

It is an important, common cause of long-term hip dysfunction if not identified and treated during the critical early period of infancy and childhood. During this period the hip joint retains substantial capacity for normal remodelling in response to treatment.

Universal or selective screening (according to national or regional protocols) is an essential component of routine newborn and infant care. It uses structured clinical examination, supported by targeted ultrasound in higher-risk infants. The aim is early detection and treatment before remodelling capacity diminishes with age.

Pathophysiology and risk factors

  • Normal hip development depends on adequate, concentric reduction of the femoral head within a well-formed acetabulum during fetal and early postnatal development. Developmental dysplasia of the hip is a disruption of this process.
  • Severity ranges from mild acetabular dysplasia, through subluxation (partial displacement of the femoral head), to frank dislocation in the most severe cases. In mild acetabular dysplasia the acetabulum is shallow and underdeveloped, and the femoral head is still located but imperfectly contained.
  • Well established risk factors are breech presentation (particularly, though not exclusively, at delivery), a positive family history, female sex, first-born status, and oligohydramnios.
  • Female sex reflects a recognised, though incompletely understood, relative hormonal ligamentous laxity in female infants.
  • These risk factors inform the selective screening approach used in many healthcare settings, which targets more intensive ultrasound-based screening toward infants with one or more of them.
  • The hip joint retains substantial capacity for remodelling and adaptation in response to treatment during infancy. This potential progressively diminishes with age.
  • Early detection and treatment are therefore essential. Delayed diagnosis and treatment bring substantially less favourable outcomes and an increasing likelihood of more invasive, surgical treatment.

Related

Clinical toolsCalculators

Latest content

Atlas’ Videos

On the evidence

Doses are traceable.

Management sections cite the guideline they came from. Atlas supports clinical judgement rather than replacing it; verify against current national guidance and the patient in front of you.

Learn it.
Know it.
Own it.